vs
Side-by-side financial comparison of Arhaus, Inc. (ARHS) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $364.8M, roughly 1.4× Arhaus, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 4.1%, a 2.7% gap on every dollar of revenue. On growth, Arhaus, Inc. posted the faster year-over-year revenue change (5.1% vs -1.7%). Over the past eight quarters, Arhaus, Inc.'s revenue compounded faster (11.2% CAGR vs -0.1%).
Arhaus, Inc.ARHSEarnings & Financial Report
Arhaus, Inc. is an upscale American home furnishings company headquartered in Boston Heights, Ohio. Founded in 1986 with a focus on sustainability and artisanship in product quality, Arhaus provides a diversified assortment of specialty goods and services addressing omnichannel direct-to-consumer and business-to-business residential and commercial operations.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
ARHS vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $364.8M | $493.8M |
| Net Profit | $15.1M | $33.7M |
| Gross Margin | 38.1% | — |
| Operating Margin | 5.6% | 9.9% |
| Net Margin | 4.1% | 6.8% |
| Revenue YoY | 5.1% | -1.7% |
| Net Profit YoY | -29.1% | 10.5% |
| EPS (diluted) | $0.11 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $364.8M | $493.8M | ||
| Q3 25 | $344.6M | $492.9M | ||
| Q2 25 | $358.4M | $468.8M | ||
| Q1 25 | $311.4M | $458.4M | ||
| Q4 24 | $347.0M | $502.4M | ||
| Q3 24 | $319.1M | $511.2M | ||
| Q2 24 | $309.8M | $504.3M | ||
| Q1 24 | $295.2M | $495.1M |
| Q4 25 | $15.1M | $33.7M | ||
| Q3 25 | $12.2M | $71.7M | ||
| Q2 25 | $35.1M | $39.3M | ||
| Q1 25 | $4.9M | $20.7M | ||
| Q4 24 | $21.3M | $30.5M | ||
| Q3 24 | $9.9M | $19.4M | ||
| Q2 24 | $22.2M | $-153.0M | ||
| Q1 24 | $15.1M | $4.0M |
| Q4 25 | 38.1% | — | ||
| Q3 25 | 38.7% | — | ||
| Q2 25 | 41.4% | — | ||
| Q1 25 | 37.1% | — | ||
| Q4 24 | 40.0% | — | ||
| Q3 24 | 38.6% | — | ||
| Q2 24 | 40.1% | — | ||
| Q1 24 | 39.0% | — |
| Q4 25 | 5.6% | 9.9% | ||
| Q3 25 | 4.8% | 13.8% | ||
| Q2 25 | 13.0% | 12.8% | ||
| Q1 25 | 1.7% | 7.0% | ||
| Q4 24 | 8.2% | 7.8% | ||
| Q3 24 | 3.3% | 6.6% | ||
| Q2 24 | 9.5% | -31.3% | ||
| Q1 24 | 6.2% | 3.2% |
| Q4 25 | 4.1% | 6.8% | ||
| Q3 25 | 3.5% | 14.5% | ||
| Q2 25 | 9.8% | 8.4% | ||
| Q1 25 | 1.6% | 4.5% | ||
| Q4 24 | 6.1% | 6.1% | ||
| Q3 24 | 3.1% | 3.8% | ||
| Q2 24 | 7.2% | -30.3% | ||
| Q1 24 | 5.1% | 0.8% |
| Q4 25 | $0.11 | $0.40 | ||
| Q3 25 | $0.09 | $0.84 | ||
| Q2 25 | $0.25 | $0.46 | ||
| Q1 25 | $0.03 | $0.24 | ||
| Q4 24 | $0.15 | $0.37 | ||
| Q3 24 | $0.07 | $0.23 | ||
| Q2 24 | $0.16 | $-1.84 | ||
| Q1 24 | $0.11 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $253.4M | $375.2M |
| Total DebtLower is stronger | — | $570.5M |
| Stockholders' EquityBook value | $418.2M | $865.9M |
| Total Assets | $1.4B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $253.4M | $375.2M | ||
| Q3 25 | $262.2M | $340.1M | ||
| Q2 25 | $234.8M | $224.7M | ||
| Q1 25 | $214.4M | $99.0M | ||
| Q4 24 | $197.5M | $229.9M | ||
| Q3 24 | $177.7M | $103.8M | ||
| Q2 24 | $174.2M | $19.4M | ||
| Q1 24 | $233.2M | $8.0M |
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $418.2M | $865.9M | ||
| Q3 25 | $400.4M | $890.7M | ||
| Q2 25 | $385.6M | $833.8M | ||
| Q1 25 | $348.8M | $789.2M | ||
| Q4 24 | $343.7M | $764.9M | ||
| Q3 24 | $320.6M | $732.5M | ||
| Q2 24 | $309.3M | $706.5M | ||
| Q1 24 | $285.6M | $856.2M |
| Q4 25 | $1.4B | $2.2B | ||
| Q3 25 | $1.4B | $2.2B | ||
| Q2 25 | $1.3B | $2.1B | ||
| Q1 25 | $1.3B | $2.0B | ||
| Q4 24 | $1.2B | $2.2B | ||
| Q3 24 | $1.2B | $2.1B | ||
| Q2 24 | $1.2B | $2.0B | ||
| Q1 24 | $1.2B | $2.2B |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.3M | $114.1M |
| Free Cash FlowOCF − Capex | $-8.8M | — |
| FCF MarginFCF / Revenue | -2.4% | — |
| Capex IntensityCapex / Revenue | 5.0% | — |
| Cash ConversionOCF / Net Profit | 0.62× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $59.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.3M | $114.1M | ||
| Q3 25 | $46.1M | $137.3M | ||
| Q2 25 | $34.9M | $137.2M | ||
| Q1 25 | $46.5M | $-117.5M | ||
| Q4 24 | $31.7M | $133.0M | ||
| Q3 24 | $31.1M | $91.8M | ||
| Q2 24 | $47.5M | $107.0M | ||
| Q1 24 | $36.8M | $-125.2M |
| Q4 25 | $-8.8M | — | ||
| Q3 25 | $28.0M | — | ||
| Q2 25 | $20.9M | — | ||
| Q1 25 | $18.9M | — | ||
| Q4 24 | $13.0M | — | ||
| Q3 24 | $4.6M | — | ||
| Q2 24 | $11.3M | — | ||
| Q1 24 | $10.9M | — |
| Q4 25 | -2.4% | — | ||
| Q3 25 | 8.1% | — | ||
| Q2 25 | 5.8% | — | ||
| Q1 25 | 6.1% | — | ||
| Q4 24 | 3.7% | — | ||
| Q3 24 | 1.4% | — | ||
| Q2 24 | 3.6% | — | ||
| Q1 24 | 3.7% | — |
| Q4 25 | 5.0% | — | ||
| Q3 25 | 5.3% | — | ||
| Q2 25 | 3.9% | — | ||
| Q1 25 | 8.9% | — | ||
| Q4 24 | 5.4% | — | ||
| Q3 24 | 8.3% | — | ||
| Q2 24 | 11.7% | — | ||
| Q1 24 | 8.8% | — |
| Q4 25 | 0.62× | 3.39× | ||
| Q3 25 | 3.77× | 1.91× | ||
| Q2 25 | 1.00× | 3.49× | ||
| Q1 25 | 9.53× | -5.66× | ||
| Q4 24 | 1.49× | 4.36× | ||
| Q3 24 | 3.14× | 4.72× | ||
| Q2 24 | 2.14× | — | ||
| Q1 24 | 2.44× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ARHS
| Sales Channel Retail | $305.7M | 84% |
| Sales Channel E Commerce | $59.2M | 16% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
